3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
2
Gynecologic
1
Conditions
Carcinoma, Ovarian Epithelial
9
Breast Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Myeloproliferative Disorders
5
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Congenital Abnormalities
5
Burkitt Lymphoma
5
Testicular Neoplasms
4
Sezary Syndrome
4
Primary Myelofibrosis
4
Pdgfra-Associated Chronic Eosinophilic Leukemia
4
Ovarian Neoplasms
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia, Neutrophilic, Chronic
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Leukemia, Myeloid, Acute
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Hairy Cell
4
Interventions
Colposcopy
5
Polymerase Chain Reaction
4
Biopsy
4
Watchful Waiting
2
Vaginal Smears
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Histological Techniques
2
Cidofovir
2
human papillomavirus vaccine, TA
1
human papillomavirus vaccine, L1 type 16, 18
1
Zoledronic Acid
1
Tretinoin
1
Transurethral Resection of Prostate
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Radiotherapy
1
Pregnancy Tests
1
Papanicolaou Test
1
Mindfulness-Based Stress Reduction
1
Microarray Analysis
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Gene Expression Profiling
1
Folic Acid
1
Fluorophotometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Flow Cytometry
×
Gynecologic
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled